Skip to main
CBLL

Ceribell Inc (CBLL) Stock Forecast & Price Target

Ceribell Inc (CBLL) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CeriBell is a promising MedTech company with a Buy rating as its Ceribell System, designed for rapid EEG monitoring, has gained significant commercial traction and is supported by strong financials. Additionally, the company has a solid pipeline, including new indications like delirium and ischemic stroke detection, which could further drive growth. Despite potential risks related to tariffs and competition, CeriBell's unique offerings and commercial strategy make it a strong investment opportunity.

Bears say

CeriBell is facing growing competition from companies like Zeto Inc. and may struggle to maintain market share. Their 2026 growth drivers are highly dependent on expanding within existing and new accounts and may not materialize as expected. Risks such as geopolitical tensions and R&D efforts may also impact the company's performance and ability to meet investors' expectations.

Ceribell Inc (CBLL) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ceribell Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ceribell Inc (CBLL) Forecast

Analysts have given Ceribell Inc (CBLL) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Ceribell Inc (CBLL) has a Strong Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ceribell Inc (CBLL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.